JOY G CAVALARIS

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology LAKE WORTH, FL NPI 1164535100

General Payments — all program years on this page

$3,270.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 160
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $415.07 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $415.0718

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Sumitomo Pharma America, Inc. $170.128
Astellas Pharma US Inc $105.184
Exact Sciences Corporation $62.812
PFIZER INC. $38.412
MILLICENT US INC $21.491
Exeltis, USA Inc. $17.061

By program year

Program yearAmountRecords
2018 $278.5518
2019 $412.0831
2020 $218.1913
2021 $430.4224
2022 $809.5329
2023 $706.6727
2024 $415.0718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114610607 Exact Sciences Corporation $29.75 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114610611 Exact Sciences Corporation $33.06 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131366142 PFIZER INC. $19.08 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131893648 PFIZER INC. $19.33 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139282820 Astellas Pharma US Inc $27.33 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139336636 Astellas Pharma US Inc $24.32 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139432400 Astellas Pharma US Inc $25.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139437044 Astellas Pharma US Inc $28.53 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148835995 Sumitomo Pharma America, Inc. $21.79 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148835997 Sumitomo Pharma America, Inc. $2.89 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148835999 Sumitomo Pharma America, Inc. $27.22 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148836001 Sumitomo Pharma America, Inc. $30.15 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148836003 Sumitomo Pharma America, Inc. $21.67 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148836005 Sumitomo Pharma America, Inc. $27.22 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148836007 Sumitomo Pharma America, Inc. $16.72 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148836009 Sumitomo Pharma America, Inc. $22.46 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149990250 Exeltis, USA Inc. $17.06 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150905506 MILLICENT US INC $21.49 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.